Search results
Results From The WOW.Com Content Network
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file
The historical application of biotechnology throughout time is provided below in chronological order.. These discoveries, inventions and modifications are evidence of the application of biotechnology since before the common era and describe notable events in the research, development and regulation of biotechnology.
Biotechnology Advances is a peer-reviewed scientific journal which focuses on the biotechnology principles and industry applications of research in agriculture, medicine, and the environment. Abstracting and indexing
Download as PDF; Printable version; ... 2008; 2009; 2010; ... Pages in category "Biotechnology companies established in 2008" The following 13 pages are in this ...
The year 2009 involved numerous significant scientific events and discoveries, some of which are listed below. 2009 was designated the International Year of Astronomy by the United Nations. [ 1 ] Events, discoveries and inventions
or the increasingly popular membrane technology that is mercury free and more energy-efficient. Worldwide there are approximately fifty mercury cell chlor-alkali plants in operation [1]. Of those there are eight in the United States (US) [2]. In 2003 the EPA reported in the Federal Register that on average approximately seven tons of mercury
Advances followed that allowed scientists to manipulate and add genes to a variety of different organisms and induce a range of different effects. Plants were first commercialized with virus resistant tobacco released in China in 1992. The first genetically modified food was the Flavr Savr tomato marketed in 1994. By 2010, 29 countries had ...
In March 2008, Celgene acquired Pharmion Corporation for $2.9 billion. [9] In January 2010, Celgene acquired Gloucester Pharmaceuticals. [10] In June 2010, Celgene agreed to acquire Abraxis BioScience. [11] It purchased the biotechnology company for $2.9 billion in its expansion into drugs that attack solid tumors. [12]